Can Volumetric modulated arc radiotherapy spare the thyroid gland in the treatment of head and neck cancers
Phase 2
Completed
- Conditions
- Health Condition 1: C01- Malignant neoplasm of base of tongueHealth Condition 2: C13- Malignant neoplasm of hypopharynxHealth Condition 3: C10- Malignant neoplasm of oropharynxHealth Condition 4: C02- Malignant neoplasm of other and unspecified parts of tongueHealth Condition 5: C321- Malignant neoplasm of supraglottis
- Registration Number
- CTRI/2020/06/025863
- Lead Sponsor
- ONE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 26
Inclusion Criteria
1 Squamous cell carcinoma of the oral cavity,
oropharynx, supraglottic larynx and hypopharynx
2 Locally advanced disease (Stage III , IV)
3 Histological proof of malignancy
4 Patients treated with radical intent
Exclusion Criteria
1. Patients with Nasopharyngeal malignancies
2. Patients who have thyroid dysfunction or are known to have thyroid dysfunction during baseline investigations
3. Prior radiotherapy, chemotherapy or head and neck surgery
4.Thyroid malignancies or tumours involving the thyroid gland
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method